MORGAN STANLEY - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 85 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$22,000
-71.8%
34,695
-80.2%
0.00%
Q2 2016$78,000
-98.6%
175,592
-96.7%
0.00%
-100.0%
Q1 2016$5,520,000
-63.7%
5,258,293
+1.9%
0.00%
-66.7%
Q4 2015$15,222,000
+44670.6%
5,160,043
+48456.0%
0.01%
Q3 2015$34,000
-76.6%
10,627
-56.5%
0.00%
Q2 2015$145,000
+11.5%
24,448
+101.5%
0.00%
Q1 2015$130,000
-31.2%
12,134
-39.6%
0.00%
Q4 2014$189,000
+60.2%
20,081
+30.1%
0.00%
Q3 2014$118,000
-60.1%
15,430
-53.2%
0.00%
Q2 2014$296,000
+190.2%
32,970
+72.7%
0.00%
Q1 2014$102,000
+1600.0%
19,093
+718.0%
0.00%
Q4 2013$6,000
-85.7%
2,334
-79.9%
0.00%
Q2 2013$42,00011,6170.00%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q3 2014.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders